Respicardia Garners $6,000,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    12400 Whitewater Dr Minnetonka, MN 55343
  • Company Description
    Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The money will be used for working capital and to complete a pilot study of the company’s sleep apnea treatment.
  • M&A Terms
  • Venture Investor
    Ares Capital

Trending on Xconomy